Literature DB >> 2304331

Cationization of bovine serum albumin alters its conformation as well as its charge.

P S Bass1, A F Drake, Y Wang, J H Thomas, D R Davies.   

Abstract

The molecular charge on bovine serum albumin (BSA) was modified by substituting carboxyl groups on the protein with ethylenediamine, thereby producing a highly cationic derivative with a pI of 9.3 to 9.5. Gel-filtration studies showed that the molecular weight of BSA was not significantly altered after cationization. When the cationized BSA was administered to rabbits using a chronic serum sickness schedule of injections, the animals developed a membranous glomerulopathy similar to the human disease, except that approximately one-third of the animals also showed focal and segmental endocapillary proliferation. Comparison of the circular dichroism spectra of native and cationized BSA showed that the substitution of the carboxyl groups resulted in a 50% reduction in the alpha-helical content of the native molecule. This conformational change should be considered as a possible determinant of the different immune response and immunopathology associated with the cationized molecule compared with native BSA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304331

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  4 in total

Review 1.  Pathogenesis of membranous nephropathy: recent advances and future challenges.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

Review 2.  Immunopathogenesis of membranous nephropathy: an update.

Authors:  Hanna Debiec; Pierre Ronco
Journal:  Semin Immunopathol       Date:  2014-04-09       Impact factor: 9.623

3.  Vascular permeability in a human tumour xenograft: molecular charge dependence.

Authors:  M Dellian; F Yuan; V S Trubetskoy; V P Torchilin; R K Jain
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

Review 4.  Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.

Authors:  Hua Miao; Yamei Zhang; Xiaoyong Yu; Liang Zou; Yingyong Zhao
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.